Welcome to our dedicated page for Alphatec Holdings news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Holdings stock.
Alphatec Holdings, Inc. (ATEC) is a leading medical technology company specializing in innovative spine surgery solutions. Our primary focus is the design, development, launch, and delivery of spinal fusion products aimed at improving patient outcomes. By collaborating with spine surgeons, we create and develop products and systems that address the entire spinal fusion procedure, enhancing efficiency and effectiveness.
At Alphatec Spine, we are committed to driving growth through constant innovation. Our product portfolio includes advanced technologies such as Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion. Each of these solutions is designed to simplify surgical procedures for surgeons, ultimately leading to superior patient outcomes.
We pride ourselves on our relentless pursuit of superior outcomes. By continuously developing technologies that positively impact patient care, we strive to be at the forefront of the medical technology industry. Our mission is to improve lives by providing cutting-edge spine surgery solutions.
For more detailed information about our products and ongoing projects, please visit our website at www.alphatecspine.com.
Latest News:
- --- Source: Alphatec Holdings, Inc.
- ---
- ---
- Source: Spineology Inc.
- ---
- ---
Alphatec Holdings, Inc. (NASDAQ: ATEC) has announced the pricing of an underwritten registered offering of 4,285,715 shares of common stock at a price of $14.00 per share. This move is expected to generate approximately $60 million in gross proceeds before underwriting discounts and commissions. The offering is scheduled to close on or about April 21, 2023, and the shares are being offered under a shelf registration statement that was declared effective on April 19, 2023. TD Cowen is the sole book-runner for this offering. ATEC is focused on innovative solutions for spine surgery, aiming to enhance surgical goals with its Organic Innovation Machine™ and AlphaInformatiX Platform.
Alphatec Holdings, a spine surgery solution provider, has acquired the REMI Robotic Navigation System from Fusion Robotics for $55 million. This acquisition aims to enhance ATEC’s procedural strategy by integrating advanced navigation and robotics into spinal workflows. The company expects total revenue to exceed $108 million in Q1 2023, reflecting over 52% year-over-year growth. Additionally, ATEC has raised its full-year revenue guidance to $450 million, a 28% increase from the previous year. The firm anticipates achieving break-even adjusted EBITDA in 2023 and free cash flow in 2025. A live webcast will discuss these developments, scheduled for today at 2:00 PM PT.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced it will release its first quarter financial results on May 4, 2023, after the market closes. A live webcast will be hosted at 1:30 p.m. PT / 4:30 p.m. ET. Investors can access the webcast by visiting ATEC's Investor Relations Section. Following the webcast, a replay will be available for twelve months on the website, with a dial-in replay option starting two hours after the event. ATEC focuses on revolutionizing spine surgery with innovative solutions, emphasizing their Organic Innovation Machine™ and expanding AlphaInformatiX Platform.
Alphatec Holdings, Inc. (Nasdaq: ATEC) has announced participation in key investor events. The company will present at The Needham Virtual Healthcare Conference on April 17, 2023, at 12:45pm ET, and at The Bank of America Healthcare Conference in Las Vegas, NV, on May 9, 2023, at 9:20am PT. Webcasts of these presentations will be available in the Investor Relations Section of the company’s website. Additionally, ATEC has granted 33,520 restricted stock units (RSUs) to sixteen new employees as part of its employment inducement program, which will vest over four years or upon a change of control.
Alphatec Holdings, Inc. (ATEC) reported a full-year revenue increase of 44%, reaching $351 million, and $106 million for Q4 2022, a 43% year-over-year growth. The company's adjusted EBITDA margin for Q4 improved by 750 basis points. Full-year 2022 operating expenses stood at $380 million, resulting in a GAAP operating loss of $147 million. Looking ahead, ATEC projects a revenue of approximately $438 million for 2023, indicating a 25% growth, with expectations to achieve non-GAAP adjusted EBITDA break-even.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced management participation in several upcoming investor events. These include the Cowen Healthcare Conference on March 6, 2023, in Boston at 2:10 pm ET, and the Canaccord Genuity Musculoskeletal Conference in Las Vegas on March 7, 2023, at 2:30 pm PT. Other events include a virtual presentation at the Loop Capital Markets Annual Investor Conference on March 13, 2023, and the Barclays Healthcare Conference in Miami on March 15, 2023, at 2:05 pm ET. Webcasts and archived recordings of these events will be accessible via the Company’s Investor Relations section on their website.
FAQ
What is the current stock price of Alphatec Holdings (ATEC)?
What is the market cap of Alphatec Holdings (ATEC)?
What does Alphatec Holdings, Inc. specialize in?
What are some of the key technologies developed by Alphatec Spine?
How does Alphatec Holdings, Inc. improve spine surgery procedures?
What is the mission of Alphatec Holdings, Inc.?
How does Alphatec Holdings, Inc. drive growth?
Where can I find more information about Alphatec Holdings, Inc.?
What recent achievements has Alphatec Holdings, Inc. made?
What are the main products of Alphatec Holdings, Inc.?
How does Alphatec Holdings, Inc. ensure superior patient outcomes?
Is Alphatec Holdings, Inc. involved in any partnerships?
